Screening of Lymphoma Radiotherapy-Resistant Genes with CRISPR Activation Library.

Luo, Bi-Hua; Huang, Jian-Qing; Huang, Chun-Yu; Tian, Pan; Chen, Ai-Zhen; Wu, Wei-Hao; Ma, Xiao-Mei; Yuan, Yue-Xing; Yu, Lian

Luo, Bi-Hua; Huang, Jian-Qing; Huang, Chun-Yu; Tian, Pan; Chen, Ai-Zhen; Wu, Wei-Hao; Ma, Xiao-Mei; Yuan, Yue-Xing; Yu, Lian.

Afiliación

Luo BH; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Huang JQ; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Huang CY; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Tian P; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Chen AZ; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Wu WH; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Ma XM; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Yuan YX; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.
Yu L; Department of Hematology, Longyan First Hospital Affiliated Fujian Medical University, Fujian, People's Republic of China.

Pharmgenomics Pers Med ; 16: 67-80, 2023.

Article en En | MEDLINE | ID: mdl-36743888

Palabras clave

CRISPR/Cas9; gene; lymphoma; radiotherapy resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Pharmgenomics Pers Med Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google